Medicinal Potential of Isoflavonoids: Polyphenols That May Cure Diabetes

In recent years, there is emerging evidence that isoflavonoids, either dietary or obtained from traditional medicinal plants, could play an important role as a supplementary drug in the management of type 2 diabetes mellitus (T2DM) due to their reported pronounced biological effects in relation to multiple metabolic factors associated with diabetes. Hence, in this regard, we have comprehensively reviewed the potential biological effects of isoflavonoids, particularly biochanin A, genistein, daidzein, glycitein, and formononetin on metabolic disorders and long-term complications induced by T2DM in order to understand whether they can be future candidates as a safe antidiabetic agent. Based on in-depth in vitro and in vivo studies evaluations, isoflavonoids have been found to activate gene expression through the stimulation of peroxisome proliferator-activated receptors (PPARs) (α, γ), modulate carbohydrate metabolism, regulate hyperglycemia, induce dyslipidemia, lessen insulin resistance, and modify adipocyte differentiation and tissue metabolism. Moreover, these natural compounds have also been found to attenuate oxidative stress through the oxidative signaling process and inflammatory mechanism. Hence, isoflavonoids have been envisioned to be able to prevent and slow down the progression of long-term diabetes complications including cardiovascular disease, nephropathy, neuropathy, and retinopathy. Further thoroughgoing investigations in human clinical studies are strongly recommended to obtain the optimum and specific dose and regimen required for supplementation with isoflavonoids and derivatives in diabetic patients.     

Graph-like compacta: Characterizations and Eulerian loops

A compact graph-like space is a triple $\left(X,V,E\right)$, where $X$ is a compact, metrizable space, $V\subseteq X$ is a closed zero-dimensional subset, and $E$ is an index set such that $X⧹V\cong \text{◂+▸}E\times \left(0,1\right)$. New characterizations of compact graph-like spaces are given, connecting them to certain classes of continua, and to standard subspaces of Freudenthal compactifications of locally finite graphs. These are applied to characterize Eulerian graph-like compacta.     

具有高安全性和有效性的Ⅱ期两阶段临床试验

Ⅱ期临床试验的主要目的是对药物治疗的安全性和有效性进行评估.针对具有高安全性的Ⅱ期两阶段临床试验,给出小样本量下关于安全性和有效性的精确检验方法,并证明最大Ⅰ类错误概率与Ⅱ类错误概率分别在原假设和备择假设的边界处达到.在期望样本量最小原则下,给出最优两阶段设计的构造方法和常用设计表,供实际应用选用.     

非齐度量测度空间上Morrey-Herz空间上的广义分数次积分算子及其交换子

设(χ,d,μ)是一个同时满足上双倍条件和几何双倍条件的非齐度量测度空间,对于引进的一类非齐度量测度空间上的Morrey-Herz空间,利用非齐度量测度空间的特征,证明了广义分数次积分算子及其交换子在非齐度量测度空间上MorreyHerz空间的有界性.     

Parallel and totally geodesic hypersurfaces of non-reductive homogeneous four-manifolds

We classify totally geodesic and parallel hypersurfaces of four-dimensional non-reductive homogeneous pseudo-Riemannian manifolds.     

The differentiation operator in the space of uniformly convergent Dirichlet series

Continuity, compactness, the spectrum and ergodic properties of the differentiation operator are investigated, when it acts in the Fréchet space of all Dirichlet series that are uniformly convergent in all half-planes for each . The properties of the formal inverse of the differentiation are also investigated.     

Evaluating the potential of vaccine-induced type replacement for high-risk human papillomaviruses

Persistent infection with human papillomavirus (HPV) is the main cause of cervical cancer. Current HPV vaccines protect against both HPV-16 and -18, which are known to cause approximately 70% of cervical cancer cases worldwide. These vaccines have shown to be highly effective in preventing infection by their targeted types. However, there is a broad diversity of HPV types not targeted by the vaccines, and there is controversy about a possible increase in the prevalence of these non-targeted types after a vaccination program. Here, we propose a within-host metapopulation model to study the possibility of vaccine-induced type replacement for oncogenic types. It is generally believed that the theoretical possibility of type replacement strongly depends on the existence of natural type competition mechanisms. Nevertheless, our results suggest that type replacement is viable at the within-host level if the degree of cross-protection induced by the vaccine is low, even if there is no underlying competition among HPV types. Consequently, the impact of current HPV vaccines at both the immunological and epidemiological levels rely upon the level of cross-protection.